fosinoprilat has been researched along with Heart Failure in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Delaney, C; Garland, WT; Kostis, JB; Liao, WC; Norton, J | 1 |
Caspi, A; Greenbaum, R; Liao, WC; Mangold, B; Nouriel, H; O'Grady, P; Paz, R; Sclarovsky, S; Yee, KF; Zucchelli, P | 1 |
Burnett , JC; Chen, HH; Harty, GJ; Lainchbury, JG; Matsuda, Y | 1 |
2 trial(s) available for fosinoprilat and Heart Failure
Article | Year |
---|---|
Fosinopril: pharmacokinetics and pharmacodynamics in congestive heart failure.
Topics: Administration, Oral; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Biological Availability; Cross-Over Studies; Female; Fosinopril; Heart Failure; Humans; Injections, Intravenous; Male; Matched-Pair Analysis; Middle Aged; Prodrugs | 1995 |
Comparison of the pharmacokinetics of fosinoprilat with enalaprilat and lisinopril in patients with congestive heart failure and chronic renal insufficiency.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Enalaprilat; Female; Fosinopril; Heart Failure; Humans; Kidney Failure, Chronic; Lisinopril; Male; Middle Aged; Peptidyl-Dipeptidase A; Time Factors | 2000 |
1 other study(ies) available for fosinoprilat and Heart Failure
Article | Year |
---|---|
Endogenous natriuretic peptides participate in renal and humoral actions of acute vasopeptidase inhibition in experimental mild heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Natriuretic Factor; Blood Pressure; Cyclic GMP; Dogs; Fosinopril; Glomerular Filtration Rate; Heart Failure; Male; Neprilysin; Polysaccharides; Protease Inhibitors; Pyridines; Receptors, Atrial Natriuretic Factor; Sodium; Thiazepines | 2001 |